NYU Langone


 

2020 CheckMate 238 Update on IO in Advanced Stage Melanoma: Did Nivo Show Sustained Superior Patient Benefit vs. Ipi in High-Risk Resected Disease?

1,137 views
November 9, 2020
1 Comment
Login to view comments. Click here to Login
Videos